Loading clinical trials...

A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT00292409

A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices

The purpose of this clinical research study is to evaluate the overall effectiveness of 8 week of aripiprazole treatment.

Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Enrolling By InvitationNA

A Pilot Trial of Group Cognitive Behavioral Therapy for Psychosis (the Feeling Safe Programme)

NCT07408934 · Schizophrenia and Schizoaffective Disorder

UNKNOWNNA

D-Serine Treatment For Tardive Dyskinesia

NCT01804920 · Schizophrenia and Schizoaffective Disorder, Tardive Dyskinesia

COMPLETEDPhase 3

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

NCT00347425 · Schizophrenia and Schizoaffective Disorder

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 8, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment400

Start dateMar 2005

Last updatedNov 8, 2013

Condition

Schizophrenia and Schizoaffective Disorder

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 8, 2013Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions